Endocrine therapy resistance and next generation sequencing

Share :
Published: 17 May 2012
Views: 4133
Rating:
Save
Prof Matthew Ellis - Washington University, USA

Prof Ellis talks to ecancer at the IMProving care And Knowledge through Translational research (IMPAKT) meeting in Brussels, May 2012, about the molecular complexity of endocrine therapy resistance and the potential of next generation sequencing to facilitate drug development.

 

Filming Supported by Amgen